Amanta Healthcare Q4 Profit Falls 7%, But Full Year Profit Surges 41%

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorAarav Shah|Published at:
Amanta Healthcare Q4 Profit Falls 7%, But Full Year Profit Surges 41%
Overview

Amanta Healthcare saw its net profit fall by 7.18% to ₹5.53 crores in the fourth quarter of FY26, even as revenue increased by 8.91%. Despite this quarterly dip, the company achieved a strong 41.66% rise in net profit for the full fiscal year.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Amanta Healthcare reported its financial results for the quarter and full year ended March 31, 2026.

Mixed Quarterly Performance

For the fourth quarter, the company's standalone net profit decreased by 7.18% compared to the previous year, totaling ₹5.53 crores. This occurred even as total revenue for the quarter grew by 8.91% to ₹78.66 crores.

Strong Full-Year Results

Looking at the entire fiscal year, Amanta Healthcare posted a significant increase in net profit, up 41.66% to ₹14.88 crores. Full-year revenue also saw a rise of 5.42%, reaching ₹291.05 crores.

Factors Influencing Results

The quarterly profit decline, despite revenue growth, suggests potential pressures from increased operational costs or one-time expenses during the period. However, the robust annual performance indicates the company's overall business strength and effective management over the longer term.

Recent IPO and Asset Growth

Amanta Healthcare recently completed an Initial Public Offering (IPO) that raised ₹126 crores. This capital infusion significantly boosted the company's total assets, which grew from ₹381.76 crores to ₹557.98 crores.

Future Focus and Risks

Investors will be watching how Amanta Healthcare utilizes its remaining unutilized IPO funds, which stood at ₹52.47 crores as of March 31, 2026. The company's increased borrowings, both non-current and current, also highlight the need for careful debt management alongside the equity raised. The quarterly profit dip and rising debt levels present key risks that warrant close monitoring in future financial reports.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.